JPY 3240.0
(-0.77%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 9.61 Billion | -152.15 Billion | 253.92 Billion | 216.35 Billion | 74.58 Billion | 153.02 Billion |
Net Income | 9.64 Billion | 13.2 Billion | 15.03 Billion | 5.11 Billion | 10.96 Billion | 8.81 Billion |
Depreciation & Amortization | 2.85 Billion | 3.12 Billion | 3.24 Billion | 3.33 Billion | 3.38 Billion | 3.27 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 9.24 Billion | -166.41 Billion | 246.1 Billion | 199.97 Billion | 88.24 Billion | 144.51 Billion |
Other non-cash items | -6.42 Billion | -2.07 Billion | -10.46 Billion | 7.93 Billion | -28.01 Billion | -3.58 Billion |
Investing Cash Flow | -73.69 Billion | 227.01 Billion | -29.1 Billion | 27.35 Billion | -249.74 Billion | -7.49 Billion |
Investments in PPE | -3.92 Billion | -2.5 Billion | -2.68 Billion | -2.82 Billion | -2.54 Billion | -3.54 Billion |
Acquisitions | 338 Million | -229.07 Billion | -938 Million | -29.67 Billion | -863 Million | -1.95 Billion |
Investment purchases | -289.15 Billion | -528.25 Billion | -713.43 Billion | -543.02 Billion | -1175.01 Billion | -941.51 Billion |
Sales/Maturities of investments | 291.31 Billion | 757.32 Billion | 686.62 Billion | 572.7 Billion | 922.68 Billion | 937.31 Billion |
Other Investing Activities | -14.36 Billion | 229.51 Billion | 1.32 Billion | 30.18 Billion | 5.98 Billion | 2.2 Billion |
Financing Cash Flow | -47.83 Billion | -3.19 Billion | -1.77 Billion | -2.43 Billion | -2.51 Billion | -12.63 Billion |
Debt repayment | -13.9 Billion | -91.77 Billion | -107.52 Billion | -8.97 Billion | -111.16 Billion | -115 Million |
Dividends payments | -2.16 Billion | -2.19 Billion | -1.77 Billion | -2.36 Billion | -2.51 Billion | -2.51 Billion |
Common Stock Repurchased | -727 Million | -1 Billion | -1 Million | -72 Million | -3 Million | -8 Million |
Common Stock Issuance | - | 7 Million | 3 Million | -378.92 Billion | 5 Million | 2 Million |
Other Financing Activities | -1 Million | 91.77 Billion | 107.52 Billion | 387.9 Billion | 111.16 Billion | -10 Billion |
Accounts receivables | 657 Million | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -72.68 Billion | -166.41 Billion | 246.1 Billion | 199.97 Billion | 88.24 Billion | 156.38 Billion |
Cash at beginning of period | 1158.39 Billion | 1086.72 Billion | 863.67 Billion | 622.39 Billion | 800.08 Billion | 667.18 Billion |
Cash at end of period | 1046.47 Billion | 1158.39 Billion | 1086.72 Billion | 863.67 Billion | 622.39 Billion | 800.08 Billion |
Capital Expenditure | -3.92 Billion | -2.5 Billion | -2.68 Billion | -2.82 Billion | -2.54 Billion | -3.54 Billion |
Effect of forex changes on cash | 8 Million | 3 Million | 7 Million | 2 Million | -1 Million | 1 Million |
Net cash flow / Change in cash | -111.91 Billion | 71.67 Billion | 223.05 Billion | 241.27 Billion | -177.68 Billion | 132.89 Billion |
Free Cash Flow | 5.68 Billion | -154.65 Billion | 251.24 Billion | 213.52 Billion | 72.03 Billion | 149.47 Billion |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 4.52 Billion | 9.64 Billion | 2.63 Billion | 2.04 Billion | 1.21 Billion | 3.74 Billion |
Depreciation & Amortization | - | 2.85 Billion | - | 715 Million | 723 Million | 721 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 9.24 Billion | - | - | - | - |
Other non-cash items | -4.52 Billion | -6.42 Billion | -2.63 Billion | -2.04 Billion | -1.21 Billion | -3.74 Billion |
Investing Cash Flow | - | -73.69 Billion | - | - | - | - |
Investments in PPE | - | -3.92 Billion | - | - | - | - |
Acquisitions | - | 338 Million | - | - | - | - |
Investment purchases | - | -289.15 Billion | - | - | - | - |
Sales/Maturities of investments | - | 291.31 Billion | - | - | - | - |
Other Investing Activities | - | -14.36 Billion | - | - | - | - |
Financing Cash Flow | - | -47.83 Billion | - | - | - | - |
Debt repayment | - | -13.9 Billion | - | - | - | - |
Dividends payments | - | -2.16 Billion | - | - | - | - |
Common Stock Repurchased | - | -727 Million | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -1 Million | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | -72.68 Billion | - | - | - | - |
Cash at beginning of period | - | 1158.39 Billion | - | - | - | - |
Cash at end of period | - | 1046.47 Billion | - | 1.43 Billion | 1.44 Billion | 1.44 Billion |
Capital Expenditure | - | -3.92 Billion | - | - | - | - |
Effect of forex changes on cash | - | 8 Million | - | - | - | - |
Net cash flow / Change in cash | - | -111.91 Billion | - | 1.43 Billion | 1.44 Billion | 1.44 Billion |
Free Cash Flow | - | 5.68 Billion | - | 1.43 Billion | 1.44 Billion | 1.44 Billion |
MVL
ADVENZYMES
MGRD
ZVIA
DCNSF
VTMTF